Middle East and Africa Anticholinergic Drugs market

Synopsis
The above chart is Global Anticholinergic Drugs market [2016-2024] by Middle East and Africa

Market Dynamics

Middle-east accounted for the larger market share in 2017 in the middle east and africa anticholinergic drugs market, and is expected to reach usd 282.37 million in 2024 from usd 234.92 million in 2017.this market is projected to grow at a cagr of 2.65% during the forecast period from 2018 - 2024. oral segment accounted for the largest market share in 2017, this market is expected to reach usd 221.94 million in 2024 from usd 186.54 million in 2017. this market is projected to grow at a cagr of 2.50% during the forecast period from 2018 - 2024. however, parenteral segment is the fastest growing market, which is expected to grow at a cagr of 2.89% during the forecast period 2018 - 2024. hospital segment accounted for the largest market share in 2017, this market is expected to reach usd 208.14 million in 2024 from usd 170.87 million in 2017. this market is projected to grow at a cagr of 2.84% during the forecast period from 2018 - 2024. overactive bladder segment accounted for the largest market share in 2017, this market is expected to reach usd 113.75 million in 2024 from usd 98.67 million in 2017. this market is projected to grow at a cagr of 2.03% during the forecast period from 2018 - 2024. however, parkinson's disease segment is the fastest growing market, which is expected to grow at a cagr of 3.00% during the forecast period 2018 - 2024. synthetic compounds segment accounted for the largest market share in 2017, this market is expected to reach usd 226.46 million in 2024 from usd 185.91 million in 2017. this market is projected to grow at a cagr of 2.84% during the forecast period from 2018 - 2024. however, synthetic compounds segment is the fastest growing market, which is expected to grow at a cagr of 2.84% during the forecast period 2018 - 2024.